Cyanvac LLC is creating vaccines utilizing a unique transformative parainfluenza virus 5 (PIV5)-based carrier. Our platform allows for the production of potent, nasal vaccines that are simple to administer, transport, and manufacture. The mission of Cyanvac LLC is to address the most urgent infectious diseases globally through easily distributable vaccines.